Inicio/Acciones/KALV

KALV

USD

KalVista Pharmaceuticals Inc. Common Stock

$10.850-0.130 (-1.184%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$10.980

Máximo

$11.100

Mínimo

$10.630

Volumen

0.87M

Fundamentos de la Empresa

Capitalización de Mercado

548.2M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.19M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $7.3Actual $10.850Máximo $17.28

Noticias Relacionadas

3 nov 2025 · 12:00

BusinessWire

KalVista Pharmaceuticals to Host Third Quarter Financial Results Conference Call and Webcast on November 11, 2025

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) will host a conference call and webcast on Tuesday, November 11, 2025, at 8:30 a.m. ET to review the Company's third quarter financial results and provide an operational

KalVista Pharmaceuticals to Host Third Quarter Financial Results Conference Call and Webcast on November 11, 2025

30 oct 2025 · 11:00

BusinessWire

KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) today announced the acceptance of one abstract for late-breaking oral presentation and three for poster presentation at the American College of Allergy, Asthma &